Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · IEX Real-Time Price · USD
12.12
-0.02 (-0.16%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Cellebrite DI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2023202220212020
Market Capitalization
2,4881,6597991,445790
Market Cap Growth
101.95%107.61%-44.70%82.97%-
Enterprise Value
2,2251,3706311,263547
PE Ratio
--20.466.8820.52-84.52
PS Ratio
7.245.102.955.874.05
PB Ratio
-85.1748.4910.82-19.7012.38
P/FCF Ratio
27.2617.6269.5351.7113.09
P/OCF Ratio
24.9816.2638.8340.0811.87
EV/Sales Ratio
6.484.212.335.132.81
EV/EBITDA Ratio
42.3031.68113.7863.60-19534.86
EV/EBIT Ratio
52.5341.22-172.8398.25-92.60
EV/FCF Ratio
24.3714.5554.8945.229.07
Debt / Equity Ratio
-0.480.410.21--
Debt / EBITDA Ratio
0.250.332.77--
Debt / FCF Ratio
0.140.151.34--
Quick Ratio
1.441.501.261.331.94
Current Ratio
1.611.661.421.462.04
Asset Turnover
0.700.700.770.700.61
Interest Coverage
0.280.31---
Return on Equity (ROE)
-710.20%-251.30%319.90%-1476.10%-15.20%
Return on Assets (ROA)
-22.80%-17.60%33.10%20.00%-2.90%
Return on Capital (ROIC)
-307.83%68.76%1.17%-16.32%14.45%
Earnings Yield
-4.50%-4.89%14.53%4.87%-1.18%
FCF Yield
3.67%5.67%1.44%1.93%7.64%
Buyback Yield / Dilution
0.69%2.68%-20.96%-30.59%-1.76%
Total Shareholder Return
0.69%2.68%-20.96%-30.59%-1.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).